Cary Street Partners Investment Advisory LLC Biofrontera Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $2.63 Billion
- Q3 2024
About Biofrontera Inc.
- Ticker BFRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 23,551,000
- Market Cap $24.7M
- Description
- Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...